Skip to main content
Holiday Sale — Get 40% off Vantage for yourself or as a gift
Published loading...Updated

FDA Committee Unanimous on Two Gene Therapies

Summary by Ground News
The FDA's Cellular, Tissue, and Gene Therapies advisory committee met June 9-10 to consider the two products. The votes each day were unanimously in favor of the products. If approved, beti-cel will be the first potentially curative gene therapy for transfusion-dependent beta-thalassemia.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

ReadMagazine broke the news in on Monday, June 13, 2022.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal